二尖瓣脱垂

Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014 Jun 10;129(23):e521-643.

• 全文
• 摘要

Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075-28.

• 全文
• 摘要

Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-91.

• 全文
• 摘要

1.  Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014 Jun 10;129(23):e521-643.

• 全文
• 摘要

2.  Freed LA, Benjamin EJ, Levy D, et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham heart study. J Am Coll Cardiol. 2002 Oct 2;40(7):1298-304.

• 全文
• 摘要

3.  Marks AR, Choong CY, Sanfilippo AJ, et al. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med. 1989 Apr 20;320(16):1031-6.

• 摘要

4.  Nishimura RA, McGoon MD, Shub C, et al. Echocardiographically documented mitral valve prolapse: long-term follow-up of 237 patients. N Engl J Med. 1985 Nov 21;313(21):1305-9.

• 摘要

5.  Levine RA, Triulzi MO, Harrigan P, et al. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation. 1987 Apr;75(4):756-67.

• 摘要

6.  Levine RA, Stathogiannis E, Newell JB, et al. Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 1988 May;11(5):1010-9.

• 全文
• 摘要

7.  Warth DC, King ME, Cohen JM, et al. Prevalence of mitral valve prolapse in normal children. J Am Coll Cardiol. 1985 May;5(5):1173-7.

• 全文
• 摘要

8.  Savage DD, Garrison RJ, Devereux RB, et al. Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham study. Am Heart J. 1983 Sep;106(3):571-6.

• 摘要

9.  Shell WE, Walton JA, Clifford ME, et al. The familial occurrence of the syndrome of mid-late systolic click and late systolic murmur. Circulation. 1969 Mar;39(3):327-37.

• 摘要

10.  Savage DD, Devereux RB, Garrison RJ, et al. Mitral valve prolapse in the general population; 2. Clinical features: the Framingham study. Am Heart J. 1983 Sep;106(3):577-81.

• 摘要

11.  Lee WR, Sheikh MU, Lee KJ. Prevalence of mitral valve prolapse in presumably healthy Korean adults. Clin Cardiol. 1985 Jun;8(6):356-8.

• 全文
• 摘要

12.  Theal M, Sleik K, Anand S, et al. Prevalence of mitral valve prolapse in ethnic groups. Can J Cardiol. 2004 Apr;20(5):511-5.

• 摘要

13.  Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 1999 Nov;65(5):1242-51.

• 全文
• 摘要

14.  Freed LA, Acierno JS Jr., Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 2003 Jun;72(6):1551-9.

• 全文
• 摘要

15.  Nesta F, Leyne M, Yosefy C, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation. 2005 Sep 27;112(13):2022-30.

• 全文
• 摘要

16.  Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999 Jul 1;341(1):1-7.

• 全文
• 摘要

17.  Devereux RB, Hawkins I, Kramer-Fox R, et al. Complications of mitral valve prolapse: disproportionate occurrence in men and older patients. Am J Med. 1986 Nov;81(5):751-8.

• 摘要

18.  Davies MJ, Moore BP, Braimbridge MV. The floppy mitral valve: study of incidence, pathology, and complications in surgical, necropsy, and forensic material. Br Heart J. 1978 May;40(5):468-81.

• 全文
• 摘要

19.  King BD, Clark MA, Baba N, et al. "Myxomatous" mitral valves: collagen dissolution as the primary defect. Circulation. 1982 Aug;66(2):288-96.

• 摘要

20.  Hirata K, Triposkiadis F, Sparks E, et al. The Marfan syndrome: cardiovascular physical findings and diagnostic correlates. Am Heart J. 1992 Mar;123(3):743-52.

• 摘要

21.  Leier CV, Call TD, Fulkerson PK, et al. The spectrum of cardiac defects in the Ehlers Danlos syndrome, types I and III. Ann Intern Med. 1980 Feb;92(2 Pt 1):171-8.

• 摘要

22.  Lebwohl MG, Distefano D, Prioleau PG, et al. Pseudoxanthoma elasticum and mitral valve prolapse. N Engl J Med. 1982 Jul 22;307(4):228-31.

• 摘要

23.  Griffin BP. Timing of surgical intervention in chronic mitral regurgitation: is vigilance enough? Circulation. 2006 May 9;113(18):2169-72.

• 全文
• 摘要

24.  Lax D, Eicher M, Goldberg SJ. Mild dehydration induces echocardiographic signs of mitral valve prolapse in healthy females with prior normal cardiac findings. Am Heart J. 1992 Dec;124(6):1533-40.

• 摘要

25.  Schreiber TL, Feigenbaum H, Weyman AE. Effect of atrial septal defect repair on left ventricular geometry and degree of mitral valve prolapse. Circulation. 1980 May;61(5):888-96.

• 摘要

26.  Fornes P, Heudes D, Fuzellier JF, et al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol. 1999 Mar-Apr;8(2):81-92.

• 摘要

27.  Attenhofer Jost CH, Turina J, Mayer K, et al. Echocardiography in the evaluation of systolic murmurs of unknown cause. Am J Med. 2000 Jun 1;108(8):614-20.

• 摘要

28.  Avierinos JF, Gersh BJ, Melton LJ 3rd, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002 Sep 10;106(11):1355-61.

• 全文
• 摘要

29.  Takamoto T, Nitta M, Tsujibayashi T, et al. The prevalence and clinical features of pathologically abnormal mitral valve leaflets (myxomatous mitral valve) in the mitral valve prolapse syndrome: an echocardiographic and pathological comparative study [in Japanese]. J Cardiol Suppl. 1991;25:75-86.

• 摘要

30.  Zuppiroli A, Mori F, Favilli S, et al. Arrhythmias in mitral valve prolapse: relation to anterior mitral leaflet thickening, clinical variables, and color Doppler echocardiographic parameters. Am Heart J. 1994 Nov;128(5):919-27.

• 摘要

31.  Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article – a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). Circulation. 2003 Sep 2;108(9):1146-62.

• 全文
• 摘要

32.  Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075-28.

• 全文
• 摘要

33.  Olson LJ, Subramanian R, Ackermann DM, et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc. 1987 Jan;62(1):22-34.

• 摘要

34.  Wilcken DE, Hickey AJ. Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgery. Circulation. 1988 Jul;78(1):10-4.

• 摘要

35.  Hayek, E, Gring GN, Griffin BP. Mitral valve prolapse. Lancet. 2005 Feb 5-11;365(9458):507-18.

• 摘要

36.  Winkle RA, Lopes MG, Goodman DJ, et al. Propranolol for patients with mitral valve prolapse. Am Heart J. 1977 Apr;93(4):422-7.

• 摘要

37.  Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul;45(7):2160-236.

• 全文
• 摘要

38.  Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e601S-36S.

• 全文
• 摘要

39.  Scottish Intercollegiate Guidelines Network. Antithrombotics: indications and management: a national clinical guideline. Jun 2013 [internet publication].

• 全文

40.  Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017 Mar 15;135(25):e1159-95.

• 全文
• 摘要

41.  Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-91.

• 全文
• 摘要

42.  Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation. 1997 Jul 1;96(1):358-66.

• 全文
• 摘要

43.  Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol. 2005 Dec 6;46(11):2134-40.

• 摘要

44.  Feldman T, Kar S, Rinaldi M, et al; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009 Aug 18;54(8):686-94.

• 全文
• 摘要

45.  Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013 Jul 23;62(4):317-28.

• 全文
• 摘要

46.  Foster E, Kwan D, Feldman T, et al; EVEREST Investigators. Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling. Circ Cardiovasc Imaging. 2013 Jul;6(4):522-30.

• 全文
• 摘要

47.  Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities – general considerations. J Am Coll Cardiol. 2005 Apr 19;45(8):1318-21.

• 摘要

48.  Maron BJ, Ackerman MJ, Nishimura RA, et al. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005 Apr 19;45(8):1340-5.

• 全文
• 摘要

49.  Barber JE, Kasper FK, Ratliff NB, et al. Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg. 2001 Nov;122(5):955-62.

• 摘要

50.  Frary CJ, Devereux RB, Kramer-Fox R, et al. Clinical and health care cost consequences of infective endocarditis in mitral valve prolapse. Am J Cardiol. 1994 Feb 1;73(4):263-7.

• 摘要

51.  Kligfield P, Levy D, Devereux RB, et al. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J. 1987 May;113(5):1298-307.

• 摘要

52.  Orencia AJ, Petty GW, Khandheria BK, et al. Risk of stroke with mitral valve prolapse in population-based cohort study. Stroke. 1995 Jan;26(1):7-13.

• 全文
• 摘要

53.  Avierinos JF, Brown RD, Foley DA, et al. Cerebral ischemic events after diagnosis of mitral valve prolapse: a community-based study of incidence and predictive factors. Stroke. 2003 Jun;34(6):1339-44.

• 全文
• 摘要

54.  Kligfield P, Hochreiter C, Kramer H, et al. Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation. Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1545-9.

• 摘要